In its upcoming report, Synchrony (SYF) is predicted by Wall Street analysts to post quarterly earnings of $1.34 per share, reflecting an increase of 1.5% compared to the same period last year. Revenues are forecasted to be $4.47 billion, representing a year-over-year increase of 6.9%. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 8.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. Bearing this in mind, let's now explore the average estimates of specific Synchrony metrics that are commonly monitored and projected by Wall Street analysts. The consensus among analysts is that 'Efficiency Ratio' will reach 34.1%. Compared to the current estimate, the company reported 35.5% in the same quarter of the previous year. Analysts predict that the 'Net interest margin' will reach 14.4%. The estimate compares to the year-ago value of 14.9%. Analysts forecast 'Net charge-offs as of average loan receivables' to reach 6.2%. Compared to the current estimate, the company reported 4.8% in the same quarter of the previous year. Based on the collective assessment of analysts, 'Total interest-earning assets - Average Balance' should arrive at $124.37 billion. The estimate compares to the year-ago value of $110.64 billion. The consensus estimate for 'Platform Analysis - Digital - Period-end loan receivables' stands at $28.38 billion. The estimate is in contrast to the year-ago figure of $25.76 billion. The combined assessment of analysts suggests that 'Platform Analysis - Home & Auto - Average loan receivables, including held for sale' will likely reach $32.54 billion. Compared to the current estimate, the company reported $30.21 billion in the same quarter of the previous year. The collective assessment of analysts points to an estimated 'Platform Analysis - Diversified & Value - Purchase volume' of $16.13 billion. The estimate compares to the year-ago value of $15.36 billion. The average prediction of analysts places 'Platform Analysis - Diversified & Value - Period-end loan receivables' at $20.08 billion. Compared to the present estimate, the company reported $18.33 billion in the same quarter last year. According to the collective judgment of analysts, 'Platform Analysis - Diversified & Value - Average loan receivables, including held for sale' should come in at $19.98 billion. The estimate compares to the year-ago value of $17.94 billion. It is projected by analysts that the 'Platform Analysis - Health & Wellness - Purchase volume' will reach $4.26 billion. Compared to the present estimate, the company reported $4.02 billion in the same quarter last year. Analysts expect 'Platform Analysis - Health & Wellness - Period-end loan receivables' to come in at $15.79 billion. The estimate is in contrast to the year-ago figure of $13.33 billion. Analysts' assessment points toward 'Platform Analysis - Health & Wellness - Average loan receivables, including held for sale' reaching $15.11 billion. The estimate compares to the year-ago value of $12.86 billion. View all Key Company Metrics for Synchrony here>>> Shares of Synchrony have experienced a change of +14.5% in the past month compared to the +4.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), SYF is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synchrony Financial (SYF):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Unlocking Q2 Potential of Synchrony (SYF): Exploring Wall Street Estimates for Key Metrics
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...